Epidemiological characteristics and prognosis among patients with fibrolamellar hepatocellular carcinoma: A retrospective cohort in Mexican population

被引：0
|
作者：
Cervantes Bojalil, J. [1 ]
Diaz Romero, M. D. C. [2 ]
Salais Michaus, V. [1 ]
Saenz Mamani, A. W. [2 ]
Zilli Hernandez, S. [1 ]
Miyagui Adame, M. [1 ]
Ruiz, E. [3 ,4 ]
Herrera, M. [1 ]
Calderillo Ruiz, G. [1 ]
Melchor-Ruan, J. [5 ]
机构：
[1] INCAN Inst Nacl Cancerol, Dept Med Oncol, Mexico City, DF, Mexico
[2] INCAN Inst Nacl Cancerol, Dept Oncol, Mexico City, DF, Mexico
[3] INCAN Inst Nacl Cancerol, GI Oncol Dept, Mexico City, DF, Mexico
[4] INCAN Inst Nacl Cancerol, Translat Med Lab, Mexico City, DF, Mexico
[5] INCAN Inst Nacl Cancerol, Surg Oncol, Mexico City, DF, Mexico
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
196P
引用
收藏
页码：S87 / S88
页数：2
相关论文
共 50 条
  • [1] Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma: A National Perspective
    Mayo, Skye C.
    Mavros, Michael N.
    Nathan, Hari
    Cosgrove, David
    Herman, Joseph M.
    Kamel, Ihab
    Anders, Robert A.
    Pawlik, Timothy M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 218 (02) : 196 - 205
  • [2] A Systematic Review: Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma
    Mavros, Michael N.
    Mayo, Skye C.
    Hyder, Omar
    Pawlik, Timothy M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 215 (06) : 820 - 830
  • [3] Clinical Characteristics and Prognosis of Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study Based on Population Data
    Guan, Yufan
    Gan, Yu
    An, Jiaze
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (09) : 3563 - 3573
  • [4] Molecular Characteristics of Fibrolamellar Hepatocellular Carcinoma
    Patonai, Attila
    Erdelyi-Belle, Boglarka
    Korompay, Anna
    Somoracz, Aron
    Torzsok, Peter
    Kovalszky, Ilona
    Barbai, Tamas
    Raso, Erzsebet
    Lotz, Gabor
    Schaff, Zsuzsa
    Kiss, Andras
    PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (01) : 63 - 70
  • [5] FIBROLAMELLAR CARCINOMA OF THE LIVER - AN HEPATOCELLULAR-CARCINOMA WITH FAVORABLE PROGNOSIS
    DENIS, J
    GRIPPON, P
    LEGENDRE, C
    TUBIANA, JM
    LEVY, VG
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1984, 8 (12): : 920 - 924
  • [6] Outcome of patients with fibrolamellar hepatocellular carcinoma
    Stipa, F
    Yoon, SS
    Liau, KH
    Fong, YM
    Jarnagin, WR
    D'Angelica, M
    Abou-Alfa, G
    Blumgart, LH
    DeMatteo, RP
    CANCER, 2006, 106 (06) : 1331 - 1338
  • [7] CHARACTERISTICS OF FIBROLAMELLAR HEPATOCELLULAR CARCINOMA PATIENTS BY RACE: SEER DATABASE STUDY
    Sempokuya, Tomoki
    Khoury, Nathalie
    Wong, Linda L.
    HEPATOLOGY, 2021, 74 : 622A - 622A
  • [8] Impact of Traditional Chinese Medicine on Prognosis of Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study
    Yuan, Huixin
    Niu, Qianqian
    Shang, Xiaofei
    Zhang, Liang
    Li, Li
    Yang, Huasheng
    Gou, Chunyan
    Li, Jingying
    Li, Hongyan
    Li, Xiuhui
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [9] Characteristics of viral hepatitis in patients with hepatocellular carcinoma in a large retrospective Australian cohort
    Alshiwanna, B.
    Blackmore, C.
    Di Girolamo, J.
    Prakoso, E.
    Prince, D. S.
    Levy, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 49 - 49
  • [10] Prognosis of fibrolamellar and non fibrolamellar hepatocellular carcinoma (HCC) in patients without liver fibrosis: Implications for liver transplantation.
    Regimbeau, JM
    Durand, F
    Kianmanesh, R
    Farges, O
    Sauvant, A
    Belghiti, J
    HEPATOLOGY, 2001, 34 (04) : 284A - 284A
12345